[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367116-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367116-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","malignant-transformation-of-proliferative-verrucous-leukoplakia-systematic-review-meta-analysis","Malignant transformation of proliferative Verrucous Leukoplakia - systematic review & meta-analysis","","Proliferative Verrucous Leukoplakia (PVL) is a rare oral leukoplakia variant marked by rapid progression, dynamic clinical and histopathological evolution, and substantial risk of malignant transformation. This systematic review examines PVL lesions that progress to cancer, summarizing demographic patterns, risk factors, progression routes, treatment choices, and patient outcomes. Searches covered multiple databases from 1985 to December 2023, and included studies were synthesized with bias assessed by Joanna Briggs Institute criteria and outcomes evaluated using CMA 3.0.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/malignant-transformation-of-proliferative-verrucous-leukoplakia-systematic-review-meta-analysis/367116/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/malignant-transformation-of-proliferative-verrucous-leukoplakia-systematic-review-meta-analysis/367116.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main objective of this systematic review?","Question",{"text":63,"@type":64},"To investigate demographic characteristics, risk factors, progression patterns, treatment preferences, and outcomes for PVL lesions that undergo malignant transformation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were eligible studies identified and analyzed?",{"text":68,"@type":64},"Databases including PubMed, Scopus, ScienceDirect, Web of Science, and Wiley Online Library were searched from 1985 to December 2023. Bias was assessed using Joanna Briggs Institute criteria, and outcomes were evaluated with Comprehensive Meta-Analysis (CMA) 3.0.",{"name":70,"@type":61,"acceptedAnswer":71},"What patient and clinical factors were most associated with malignant transformation?",{"text":72,"@type":64},"Most transformed cases involved invasive carcinoma, and the malignant group showed a predominance of females, older age, and frequent involvement of gingiva or gingiva/buccal mucosa.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367116,1790443862,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Mohideen etal. BMCOral Health (2025) 25:175 [https://doi.org/10.1186/s12903-025-05565-7](https://doi.org/10.1186/s12903-025-05565-7)  \nBMC Oral Health  \n SYSTEMATIC REVIEW Open Access  \nMalignant transformation of proliferative   Verrucous Leukoplakia—systematic review & meta-analysis  \nKhadijah Mohideen 1, Snehashish Ghosh2*, Chandrasekaran Krithika3, Mutaz Ali‑Hassan1, Revant Chole1 and Safal Dhungel4  \nAbstract  \nBackground Proliferative Verrucous Leukoplakia (PVL) presents a unique manifestation of Oral Leukoplakia, char‑ acterized by its notable propensity for rapid advancement, dynamic clinical and histopathological alterations, and heightened risk of malignant transformation.  \nAim The present systematic review explores the demographic characteristics, risk factors, progression patterns, treat‑ ment preferences, and outcomes for PVL lesions that undergo malignant transformation.  \nMaterials and methods An electronic search was executed across various databases, such as PubMed, Scopus, Science Direct, Web of Science and Wiley Online Library from 1985 to December 2023, focusing on studies of PVL malignant transformation. Data on demographics, clinical features, treatment, and outcome data were synthesized, with bias assessed using Joanna Briggs Institute Criteria and outcomes evaluated using Comprehensive Meta‑Analysis version (CMA) 3.0 software.  \nResults Among 998 articles, 53 met inclusion criteria, covering 1159 PVL patients, with 48.4% experiencing malignant transformation over an average 6.28 ± 3 . 73—year follow‑up. Most cases had low or moderate bias risk. In the malig‑ nant group, females comprised 74 . 3% of cases, with a mean age of 66.23 ± 7.76 years and had a 1.96 times greater risk of developing cancer (OR 1. 96, 95% CI 1.38—2. 782; p = 0 . 001) . Gingiva (20%) and gingiva/buccal mucosa (17 .4%) were commonly affected. Tobacco and alcohol showed weak associations, with most patients being non‑smokers (59 . 54%) and non‑drinkers (78 . 18%) . HPV and candida infection positivity were tested in only a few studies and noted in a lim‑ ited number of cases (33 . 3% and 38.46%, respectively) . Malignant transformation mainly was invasive carcinoma (86 . 8%) . Surgery was the primary treatment (58 . 33%), with 55. 56% recurrence in 162 cases of data availability on recur‑ rence. Of 228 patients with data availability, 33. 77% succumbed to oral cancer from PVL‑related oral cancer. Conclusions PVL, a rare variant of leukoplakia, poses a significant risk of cancer, emphasizing the need for vigilant monitoring and proactive treatment. It mainly affects elderly females without typical cancer risk factors. Understand‑ ing its etiology could aid early detection and management.  \nKeywords Proliferative verrucous leukoplakia, Malignant transformation, Oral cancer, Squamous cell carcinoma, Verrucous Carcinoma  \n*Correspondence: Snehashish Ghosh [drsnehashishop@gmail.com](drsnehashishop@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of ","cbCaiscR6hswHjBw","https://ap.wps.com/l/cbCaiscR6hswHjBw","pdf",6935685,23,"English","# Abstract\n## Background\n## Aim\n## Materials and methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main objective of this systematic review?\",\"answer\":\"To investigate demographic characteristics, risk factors, progression patterns, treatment preferences, and outcomes for PVL lesions that undergo malignant transformation.\"},{\"question\":\"How were eligible studies identified and analyzed?\",\"answer\":\"Databases including PubMed, Scopus, ScienceDirect, Web of Science, and Wiley Online Library were searched from 1985 to December 2023. Bias was assessed using Joanna Briggs Institute criteria, and outcomes were evaluated with Comprehensive Meta-Analysis (CMA) 3.0.\"},{\"question\":\"What patient and clinical factors were most associated with malignant transformation?\",\"answer\":\"Most transformed cases involved invasive carcinoma, and the malignant group showed a predominance of females, older age, and frequent involvement of gingiva or gingiva/buccal mucosa.\"}]","Malignant transformation of proliferative Verrucous Leukoplakia - systematic review & meta-analysis | PDF",1790169338,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5a63455c24699ad51256d2d0b8d56fe.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69a1564572de29202ca8f2b05d40c959.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2bc10d4193af62cf81d2a452d91dba6.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/058828f6b3d9926401ac8081570b195d.webp",980,1301]